Vanderbilt University School of Medicine

Sahasrabuddhe, Vikrant V. , M.B.B.S., M.P.H., Dr.P.H.
Research Associate Professor of Medicine

Lab Url: N/A

Phone Number: +1-240-276-7332

Email Address:vikrant.sahasrabuddhe@vanderbilt.edu

Sahasrabuddhe, Vikrant's picture

Office Address   Mailing Address

Currently serving on detail at the National Cancer Institute (NCI), National Institutes of Health (NIH)

NCI/NIH address: 9609 Medical Center Drive, 5E-338, Rockville, MD 20850-9783


Research Keywords
Cancer Epidemiology and Prevention, Global Health, HIV/AIDS, Cervical Cancer, Anogenital Cancers, Liver Cancer

Clinical Research Description
Dr. Vikrant Sahasrabuddhe is currently serving on detail at the National Cancer Institute (NCI), National Institutes of Health (NIH) where he is engaged in clinical epidemiology and prevention research studies on infection-associated cancers.

Publications
#1 Sahasrabuddhe VV, Gravitt PE, Dunn ST, Robbins D, Brown D, Allen RA, Eby YJ, Smith KM, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N. #1 Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. J Clin Virol, 60(4), 414-7, 2014.

#2 Sahasrabuddhe VV, Gravitt PE, Dunn ST, Brown D, Allen RA, Eby YJ, Smith K, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N. #2 Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. J Clin Microbiol, 52(1), 187-92, 2014.

#3 Hagberg KW, McGlynn KA, Sahasrabuddhe VV, Jick S. #3 Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes. Br J Cancer, 111(9), 1710-7, 2014.

#4 McGlynn KA, Divine GW, Sahasrabuddhe VV, Engel LS, VanSlooten A, Wells K, Yood MU, Alford SH. #4 Statin use and risk of hepatocellular carcinoma in a U.S. population. Cancer Epidemiol, 38(5), 523-7, 2014.

#5 Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JS, Parham GP. #5 Monitoring the performance of 'screen-and-treat' cervical cancer prevention programs. Int J Gynaecol Obstet, 126(1), 88-9, 2014.

#6 Bateman AC, Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Kapambwe S, Katundu K, Nkole T, Mulundika J, Pfaendler KS, Hicks ML, Shibemba A, Vermund SH, Stringer JS, Chibwesha CJ. #6 Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. J Acquir Immune Defic Syndr, 67(2), 212-5, 2014.

#7 Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Sahasrabuddhe VV, Chen J, Lorey TS, Gage JC, Fetterman B, Boyle S, Sadorra M, Tang SD, Darragh TM, Castle PE. #7 Analytic and Clinical Performance of cobas HPV Testing in Anal Specimens from HIV-Positive Men Who Have Sex with Men. J Clin Microbiol, 52(8), 2892-7, 2014.

#8 Zhang HY, Fei MD, Jiang Y, Fei QY, Qian H, Xu L, Jin YN, Jiang CQ, Li HX, Tiggelaar SM, Smith JS, Sahasrabuddhe VV, Qiao YL. #8 The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China. Virol J, 11(1), 202, 2014.

#9 Wilson L, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N. #9 Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection. J Infect Dis, 210(3), 448-55, 2014.

#10 Sahasrabuddhe VV, Castle PE, Follansbee S, Borgonovo S, Tokugawa D, Schwartz LM, Lorey TS, Lamere BJ, Gage JC, Fetterman B, Boyle S, Sadorra M, Tang SD, Darragh TM, Wentzensen N. #10 Human Papillomavirus Genotype Attribution and Estimation of Preventable Fraction of Anal Intraepithelial Neoplasia Cases Among HIV-Infected Men Who Have Sex With Men. J Infect Dis, 207(3), 392-401, 2013.

#11 Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, Hollenbeck AR, Freedman ND, McGlynn KA. #11 Response. J Natl Cancer Inst, 105(9), 668- 71, 2013.

#12 Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. #12 Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. PLoS One, 8(8), e72565, 2013.

#13 De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP. #13 The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine, 31 Suppl 5, F32-46, 2013.

#14 Godfrey CC, Michelow PM, Godard M, Sahasrabuddhe VV, Darden J, Firnhaber CS, Wetherall NT, Bremer J, Coombs RW, Wilkin T, A5282 Study Team . #14 Improving Diagnostic Capability for HPV Disease Internationally Within the NIH-NIAID Division of AIDS Clinical Trial Networks. Am J Clin Pathol, 140(6), 881-9, 2013.

#15 Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JS, Parham GP. #15 Utilization of Cervical Cancer Screening Services and Trends in Screening Positivity Rates in a 'Screen-And-Treat' Program Integrated with HIV/AIDS Care in Zambia. PLoS One, 8(9), e74607, 2013.

#16 Schwartz LM, Castle PE, Follansbee S, Borgonovo S, Fetterman B, Tokugawa D, Lorey TS, Sahasrabuddhe VV, Luhn P, Gage JC, Darragh TM, Wentzensen N. #16 Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men. J Infect Dis, 208(11), 1768-75, 2013.

#17 Wilson LE, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N. #17 Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. Int J Cancer, 133(9), 2172-81, 2013.

#18 Sahasrabuddhe VV, Bhosale RA, Kavatkar AN, Nagwanshi CA, Joshi SN, Jenkins CA, Shepherd BE, Kelkar RS, Sahay S, Risbud AR, Vermund SH, Mehendale SM. #18 Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India. Int J Cancer, 130(1), 234-40, 2012.

#19 Sahasrabuddhe, VV, Sherman, ME. #19 Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality. J Natl Cancer Inst, 104(22), 1698-701, 2012.

#20 Sahasrabuddhe, VV, Gunja, MZ, Graubard, BI, Trabert, B, Schwartz, LM, Park, Y, Hollenbeck, AR, Freedman, ND, McGlynn, KA. #20 Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma. J Natl Cancer Inst, 104(23), 1808-14, 2012.

#21 Sahasrabuddhe, VV, Parham, GP, Mwanahamuntu, MH, Vermund, SH. #21 Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prev Res (Phila), 5(1), 11-7, 2012.

#22 Sahasrabuddhe, VV, Shiels, MS, McGlynn, KA, Engels, EA. #22 The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States. Cancer, 118(24), 6226-33, 2012.

#23 Brinton LA, Sahasrabuddhe VV, Scoccia B. #23 Fertility drugs and the risk of breast and gynecologic cancers. Semin Reprod Med, 30(2), 131-45, 2012.

#24 Mane, A, Nirmalkar, A, Risbud, AR, Vermund, SH, Mehendale, SM, Sahasrabuddhe, VV. #24 HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India. PLoS One, 7(6), e38731, 2012.

#25 Wentzensen, N, Follansbee, S, Borgonovo, S, Tokugawa, D, Schwartz, L, Lorey, TS, Sahasrabuddhe, VV, Lamere, B, Gage, JC, Fetterman, B, Darragh, TM, Castle, PE. #25 Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM. AIDS, 26(17), 2185-92, 2012.

#26 Zhang, HY, Tiggelaar, SM, Sahasrabuddhe, VV, Smith, JS, Jiang, CQ, Mei, RB, Wang, XG, Li, ZA, Qiao, YL. #26 HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study. Asian Pac J Cancer Prev, 13(1), 91-6, 2012. PMCID:3378535

#27 Sahasrabuddhe, VV, Luhn, P, Wentzensen, N. #27 Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol, 6, 1083-98, 2011.

#28 Chen, Z, Schiffman, M, Herrero, R, Desalle, R, Anastos, K, Segondy, M, Sahasrabuddhe, VV, Gravitt, PE, Hsing, AW, Burk, RD. #28 Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One, 6(5), e20183, 2011. PMCID:3103539

#29 Mwanahamuntu, MH, Sahasrabuddhe, VV, Kapambwe, S, Pfaendler, KS, Chibwesha, C, Mkumba, G, Mudenda, V, Hicks, ML, Vermund, SH, Stringer, JS, Parham, GP. #29 Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the cervical cancer prevention program in zambia. PLoS Med, 8(5), e1001032, 2011. PMCID:3096609

#30 Sahasrabuddhe, VV, Bhosale, RA, Joshi, SN, Kavatkar, AN, Nagwanshi, CA, Kelkar, RS, Jenkins, CA, Shepherd, BE, Sahay, S, Risbud, AR, Vermund, SH, Mehendale, SM. #30 Prevalence and Predictors of Colposcopic-Histopathologically Confirmed Cervical Intraepithelial Neoplasia in HIV-Infected Women in India. PLoS One, 5(1), e8634, 2010. PMCID:2798747

#31 Bratcher, LF, Sahasrabuddhe, VV. #31 The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. Infect Agent Cancer, 5, 8, 2010. PMCID:2881893

#32 Chirwa, S, Mwanahamuntu, M, Kapambwe, S, Mkumba, G, Stringer, J, Sahasrabuddhe, V, Pfaendler, K, Parham, G. #32 Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators. Glob Health Promot, 17(2 Suppl), 47-50, 2010. PMCID:3096609

#33 Parham, GP, Mwanahamuntu, MH, Pfaendler, KS, Sahasrabuddhe, VV, Myung, D, Mkumba, G, Kapambwe, S, Mwanza, B, Chibwesha, C, Hicks, ML, Stringer, JS. #33 eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia. J Low Genit Tract Dis, 14(3), 167-73, 2010. PMCID:3096609

#34 Parham, GP, Mwanahamuntu, MH, Sahasrabuddhe, VV, Westfall, AO, King, KE, Chibwesha, C, Pfaendler, KS, Mkumba, G, Mudenda, V, Kapambwe, S, Vermund, SH, Hicks, ML, Stringer, JS, Chi, BH. #34 Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness. HIV Ther, 4(6), 703-722, 2010.

#35 Sahasrabuddhe VV, Vermund SH. #35 Current And Future Trends: Implications For HIV Prevention. Book Chapter in Mayer KH, Pizer HF (editors) "HIV Prevention: A Comprehensive Approach" Academic Press, London, UK, , , 2009.

#36 Mwanahamuntu, MH, Sahasrabuddhe, VV, Parham, GP. #36 HPV screening for cervical cancer in rural India. N Engl J Med, 361(3), 305; author reply 306, 2009. PMCID:2798747

#37 Li, AH, Phanuphak, N, Sahasrabuddhe, VV, Chaithongwongwatthana, S, Vermund, SH, Jenkins, CA, Shepherd, BE, Teeratakulpisarn, N, van der Lugt, J, Avihingsanon, A, Ruxrungtham, K, Shikuma, C, Phanuphak, P, Ananworanich, J. #37 Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in Thailand. Sex Transm Infect, 85(7), 503-7, 2009. PMCID:2798747

#38 Mwanahamuntu, MH, Sahasrabuddhe, VV, Pfaendler, KS, Mudenda, V, Hicks, ML, Vermund, SH, Stringer, JS, Parham, GP. #38 Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS, 23(6), N1-5, 2009. PMCID:2747794

#39 Sahasrabuddhe VV, Tharpe LE, Allen KL, Vermund SH. #39 Public health interventions to prevent HIV: treatment of sexually transmitted infections and adult male circumcision. Book chapter in Marlink RG, Teitelman SJ (editors) "From the Ground Up: Building Comprehensive HIV/AIDS Programs in Resource Limited Settings" The Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, , , 2008.

#40 Parham GP, Mwanahamuntu MH, Pfaendler KS, Mkumba G, Sahasrabuddhe VV, Hicks ML, Welty E, Stringer JS. #40 Building a cervical cancer prevention program on an HIV care and treatment infrastructure in Zambia. Book chapter in Marlink RG, Teitelman SJ (editors) "From the Ground Up: Building Comprehensive HIV/AIDS Programs in Resource Limited Settings" The Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, , , 2008.

#41 Vikrant Sahasrabuddhe and Sanjay Mehendale . #41 Female sex workers and the HIV/AIDS Epidemic in India. Book chapter in Sahni R, Kalyan Shankar V, Apte H (editors) "Prostitution and Beyond: an analysis of sex work in India" Sage Publications, India, , , 2008.

#42 Joshi, SN, Das, S, Thakar, M, Sahasrabuddhe, V, Kumar, BK, Callahan, M, Mauck, C. #42 Colposcopically observed vascular changes in the cervix in relation to the hormonal levels and menstrual cycle. J Low Genit Tract Dis, 12(4), 293-9, 2008. PMCID:2747794

#43 Mwanahamuntu, MH, Sahasrabuddhe, VV, Stringer, JS, Parham, GP. #43 Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Bull World Health Organ, 86(8), D-E, 2008. PMCID:2649457

#44 Pfaendler, KS, Mwanahamuntu, MH, Sahasrabuddhe, VV, Mudenda, V, Stringer, JS, Parham, GP. #44 Management of cryotherapy-ineligible women in a 'screen-and-treat' cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol, 110(3), 402-7, 2008. PMCID:2745977

#45 Vermund, SH, Sahasrabuddhe, VV, Khedkar, S, Jia, Y, Etherington, C, Vergara, A. #45 Building global health through a center-without-walls: the Vanderbilt Institute for Global Health. Acad Med, 83(2), 154-64, 2008. PMCID:2564795

#46 Sahasrabuddhe, VV, Mwanahamuntu, MH, Vermund, SH, Huh, WK, Lyon, MD, Stringer, JS, Parham, GP. #46 Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer, 96(9), 1480-3, 2007. PMCID:2360194

#47 Sahasrabuddhe, VV, Vermund, SH. #47 The Future of HIV Prevention: Control of Sexually Transmitted Infections and Circumcision Interventions. Infect Dis Clin North Am, 21(1), 241-57, 2007. PMCID:2700301

#48 Parham, GP, Sahasrabuddhe, VV, Mwanahamuntu, MH, Shepherd, BE, Hicks, ML, Stringer, EM, Vermund, SH. #48 Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol, 103(3), 1017-22, 2006. PMCID:2748907

#49 Sahasrabuddhe, V, Makhija, S. #49 Double jeopardy: HIV and cervical cancer in Indian women. Int J Gynecol Cancer, 15(1), 1-3, 2005. PMCID:2837929

#50 Sahasrabuddhe, VV, Gholap, TA, Jethava, YS, Joglekar, NS, Brahme, RG, Gaikwad, BA, Wankhede, AK, Mehendale, SM. #50 Patient-led partner referral in a district hospital based STD clinic. J Postgrad Med, 48(2), 105-8, 2002. PMCID:2748907


Postdoctoral Position Available
N/A

Postdoctoral Position Details
N/A

Updated Date
01/05/2015



Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Copyright 2008 Vanderbilt University School of Medicine
The office of Biomedical Research Education & Training All rights reserved.
For questions or problems concerning this page, please submit a help ticket.